免疫チェックポイント阻害剤の世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Global Immune Checkpoint Inhibitors Market 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• PD-1 inhibitors – Market size and forecast 2018-2023
• CTLA-4 inhibitors – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AstraZeneca
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Merck Sharp & Dohme
• Pfizer
PART 14: APPENDIX
• List of Abbreviations
PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global oncology drugs market
Exhibit 02: Segments of global oncology drugs market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Type – Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: PD-1 inhibitors – Market size and forecast 2018-2023 ($ billions)
Exhibit 20: PD-1 inhibitors – Year-over-year growth 2019-2023 (%)
Exhibit 21: CTLA-4 inhibitors – Market size and forecast 2018-2023 ($ billions)
Exhibit 22: CTLA-4 inhibitors – Year-over-year growth 2019-2023 (%)
Exhibit 23: Others – Market size and forecast 2018-2023 ($ billions)
Exhibit 24: Others – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by type
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: Americas – Market size and forecast 2018-2023 ($ billions)
Exhibit 30: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 31: Top 3 countries in Americas
Exhibit 32: EMEA – Market size and forecast 2018-2023 ($ billions)
Exhibit 33: Patient assistance program by AstraZeneca
Exhibit 34: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2018-2023 ($ billions)
Exhibit 37: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Patient assistance programs
Exhibit 42: Combined action of PD-1 and CTLA-4 checkpoint inhibitors
Exhibit 43: Treatment costs of immune checkpoint inhibitor therapeutics in US
Exhibit 44: Side effects of immune checkpoint inhibitors
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Some of the strategic alliances in global immune checkpoint inhibitors market
Exhibit 47: Approved drugs with respect to their cancer indications
Exhibit 48: Expansion of research areas of approved drugs
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: AstraZeneca – Vendor overview
Exhibit 55: AstraZeneca – Business segments
Exhibit 56: AstraZeneca – Organizational developments
Exhibit 57: AstraZeneca – Geographic focus
Exhibit 58: AstraZeneca – Segment focus
Exhibit 59: AstraZeneca – Key offerings
Exhibit 60: AstraZeneca – Key customers
Exhibit 61: Bristol-Myers Squibb – Vendor overview
Exhibit 62: Bristol-Myers Squibb – Business segments
Exhibit 63: Bristol-Myers Squibb – Organizational developments
Exhibit 64: Bristol-Myers Squibb – Geographic focus
Exhibit 65: Bristol-Myers Squibb – Key offerings
Exhibit 66: Bristol-Myers Squibb – Key customers
Exhibit 67: F. Hoffmann-La Roche – Vendor overview
Exhibit 68: F. Hoffmann-La Roche – Business segments
Exhibit 69: F. Hoffmann-La Roche – Organizational developments
Exhibit 70: F. Hoffmann-La Roche – Geographic focus
Exhibit 71: F. Hoffmann-La Roche – Segment focus
Exhibit 72: F. Hoffmann-La Roche – Key offerings
Exhibit 73: F. Hoffmann-La Roche – Key customers
Exhibit 74: Merck Sharp & Dohme – Vendor overview
Exhibit 75: Merck Sharp & Dohme – Business segments
Exhibit 76: Merck Sharp & Dohme – Organizational developments
Exhibit 77: Merck Sharp & Dohme – Geographic focus
Exhibit 78: Merck Sharp & Dohme – Segment focus
Exhibit 79: Merck Sharp & Dohme – Key offerings
Exhibit 80: Merck Sharp & Dohme – Key customers
Exhibit 81: Pfizer – Vendor overview
Exhibit 82: Pfizer – Business segments
Exhibit 83: Pfizer – Organizational developments
Exhibit 84: Pfizer – Geographic focus
Exhibit 85: Pfizer – Segment focus
Exhibit 86: Pfizer – Key offerings
Exhibit 87: Pfizer – Key customers


【レポート販売概要】

■ タイトル:免疫チェックポイント阻害剤の世界市場2019-2023
■ 英文:Global Immune Checkpoint Inhibitors Market 2019-2023
■ 発行日:2018年11月13日
■ 調査会社:Technavio
■ 商品コード:IRTNTR30233
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。